Evaluation of brain natriuretic peptide in the diagnosis of heart failure

Area of Science:

• Cardiology
• Biomarkers
• Diagnostic Medicine

Background:

• Diagnosing heart failure (HF) can be challenging, particularly in patients presenting with subtle symptoms.
• Systolic and diastolic ventricular dysfunction are key components of HF requiring precise diagnostic methods.

Purpose of the Study:

• To assess the diagnostic utility of brain natriuretic peptide (BNP) for identifying heart failure (HF).
• To specifically evaluate BNP's accuracy in diagnosing HF with systolic or isolated diastolic ventricular dysfunction.

Main Methods:

• The study included 100 patients and 9 healthy controls.
• Diagnosis of HF was confirmed using clinical assessments and echocardiographic findings.
• Brain natriuretic peptide (BNP) levels were measured and analyzed using receiver operating characteristic (ROC) curves.

Main Results:

• BNP levels demonstrated high accuracy in diagnosing HF, with an area under the ROC curve (AUC) of 0.92.
• BNP measurement showed excellent accuracy for diagnosing isolated diastolic HF, achieving an AUC of 0.89.

Conclusions:

• BNP measurement is a valuable tool for diagnosing heart failure (HF).
• BNP levels can effectively identify patients with isolated diastolic HF.
• BNP testing assists in selecting patients who require further diagnostic evaluation for HF.